2006
DOI: 10.1007/s10495-006-5702-1
|View full text |Cite
|
Sign up to set email alerts
|

Cell death regulation by B-cell lymphoma protein

Abstract: Bcl-2 (B Cell Lymphoma) protein is an anti-apoptotic member of Bcl-2 family, which is comprised of pro- and anti-apoptotic members. It regulates cellular proliferation and death by inter- and intra-family interactions. It has a potential to suppress apoptotic cell death under variety of stress conditions by modulating mitochondrial transmembrane potential. However, prevalence of constitutively activated Bcl-2 cellular activity is not always required in cells; a mechanism likely exists in cells, which controls … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0
1

Year Published

2006
2006
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 85 publications
0
23
0
1
Order By: Relevance
“…16 It is now known that antagonizing Bcl-2 function may lead to death in many types of cancer cells. 17 We observed that in DLA cells, Bcl-2 was highly overexpressed.…”
Section: Discussionmentioning
confidence: 99%
“…16 It is now known that antagonizing Bcl-2 function may lead to death in many types of cancer cells. 17 We observed that in DLA cells, Bcl-2 was highly overexpressed.…”
Section: Discussionmentioning
confidence: 99%
“…The activation and regulation of this suicide program involves numerous intra-and extra-cellular signals and factors [54][55][56]. Induction of apoptosis frequently requires the activation of the "initiator" caspases-2, -8 and -9 [57].…”
Section: Rch Response Protects Cells Against Cold-induced Apoptosismentioning
confidence: 99%
“…Understanding the interactions of various proteins with FLD would likely help us to tweak apoptosis signaling and the treatment of various malignancies [12] in which Bcl-2 expression is not under control, such as acute myeloid leukemia (AML) [13]. Therefore, the FLD represents an attractive target for drugs that modulate protein-protein interactions, and studies of the FLD would likely facilitate drug discovery and improve our understanding of human diseases.…”
Section: Introductionmentioning
confidence: 99%